99 related articles for article (PubMed ID: 33007434)
1. A Novel Translational PET Imaging Approach to Quantifying Distal Tumor Immune Activation After Targeted Radiation Therapy and Checkpoint Blockade.
Zhang Y; Deshane JS; Yang ES; Larimer B
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1217-1227. PubMed ID: 38199384
[TBL] [Abstract][Full Text] [Related]
2. Multifaceted transforming growth factor-beta (TGFβ) signalling in glioblastoma.
Birch JL; Coull BJ; Spender LC; Watt C; Willison A; Syed N; Chalmers AJ; Hossain-Ibrahim MK; Inman GJ
Cell Signal; 2020 Aug; 72():109638. PubMed ID: 32320860
[TBL] [Abstract][Full Text] [Related]
3. TGFβ-Directed Therapeutics: 2020.
Teicher BA
Pharmacol Ther; 2021 Jan; 217():107666. PubMed ID: 32835827
[TBL] [Abstract][Full Text] [Related]
4. Monitoring TGFβ signaling in irradiated tumors.
Ma L; Gonzalez-Junca A; Chou W; Barcellos-Hoff MH
Methods Cell Biol; 2023; 180():49-67. PubMed ID: 37890932
[TBL] [Abstract][Full Text] [Related]
5. Loss of TGFβ signaling increases alternative end-joining DNA repair that sensitizes to genotoxic therapies across cancer types.
Liu Q; Palomero L; Moore J; Guix I; Espín R; Aytés A; Mao JH; Paulovich AG; Whiteaker JR; Ivey RG; Iliakis G; Luo D; Chalmers AJ; Murnane J; Pujana MA; Barcellos-Hoff MH
Sci Transl Med; 2021 Feb; 13(580):. PubMed ID: 33568520
[TBL] [Abstract][Full Text] [Related]
6. Inflammation Mediates the Development of Aggressive Breast Cancer Following Radiotherapy.
Ma L; Gonzalez-Junca A; Zheng Y; Ouyang H; Illa-Bochaca I; Horst KC; Krings G; Wang Y; Fernandez-Garcia I; Chou W; Barcellos-Hoff MH
Clin Cancer Res; 2021 Mar; 27(6):1778-1791. PubMed ID: 33402361
[TBL] [Abstract][Full Text] [Related]
7. Updates on radiotherapy-immunotherapy combinations: Proceedings of 6
Gregucci F; Spada S; Barcellos-Hoff MH; Bhardwaj N; Chan Wah Hak C; Fiorentino A; Guha C; Guzman ML; Harrington K; Herrera FG; Honeychurch J; Hong T; Iturri L; Jaffee E; Karam SD; Knott SRV; Koumenis C; Lyden D; Marciscano AE; Melcher A; Mondini M; Mondino A; Morris ZS; Pitroda S; Quezada SA; Santambrogio L; Shiao S; Stagg J; Telarovic I; Timmerman R; Vozenin MC; Weichselbaum R; Welsh J; Wilkins A; Xu C; Zappasodi R; Zou W; Bobard A; Demaria S; Galluzzi L; Deutsch E; Formenti SC
Oncoimmunology; 2023; 12(1):2222560. PubMed ID: 37363104
[TBL] [Abstract][Full Text] [Related]
8. Boron-peptide conjugates with angiopep-2 for boron neutron capture therapy.
Xiang J; Ma L; Tong J; Zuo N; Hu W; Luo Y; Liu J; Liang T; Ren Q; Liu Q
Front Med (Lausanne); 2023; 10():1199881. PubMed ID: 37324130
[TBL] [Abstract][Full Text] [Related]
9. Immunological and tumor-intrinsic mechanisms mediate the synergistic growth suppression of experimental glioblastoma by radiotherapy and MET inhibition.
Silginer M; Papa E; Szabó E; Vasella F; Pruschy M; Stroh C; Roth P; Weiss T; Weller M
Acta Neuropathol Commun; 2023 Mar; 11(1):41. PubMed ID: 36915128
[TBL] [Abstract][Full Text] [Related]
10. First pan-specific vNAR against human TGF-β as a potential therapeutic application: in silico modeling assessment.
Burciaga-Flores M; Márquez-Aguirre AL; Dueñas S; Gasperin-Bulbarela J; Licea-Navarro AF; Camacho-Villegas TA
Sci Rep; 2023 Mar; 13(1):3596. PubMed ID: 36869086
[TBL] [Abstract][Full Text] [Related]
11. ImmunoPET Directed to the Brain: A New Tool for Preclinical and Clinical Neuroscience.
de Lucas ÁG; Lamminmäki U; López-Picón FR
Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671549
[TBL] [Abstract][Full Text] [Related]
12. Molecular Pathways and Mechanisms of TGFβ in Cancer Therapy.
Barcellos-Hoff MH; Gulley JL
Clin Cancer Res; 2023 Jun; 29(11):2025-2033. PubMed ID: 36598437
[TBL] [Abstract][Full Text] [Related]
13. ImmunoPET: Antibody-Based PET Imaging in Solid Tumors.
Manafi-Farid R; Ataeinia B; Ranjbar S; Jamshidi Araghi Z; Moradi MM; Pirich C; Beheshti M
Front Med (Lausanne); 2022; 9():916693. PubMed ID: 35836956
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of Glioblastoma by Immuno-Positron Emission Tomography.
Ruiz-López E; Calatayud-Pérez J; Castells-Yus I; Gimeno-Peribáñez MJ; Mendoza-Calvo N; Morcillo MÁ; Schuhmacher AJ
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008238
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer.
Petroni G; Cantley LC; Santambrogio L; Formenti SC; Galluzzi L
Nat Rev Clin Oncol; 2022 Feb; 19(2):114-131. PubMed ID: 34819622
[TBL] [Abstract][Full Text] [Related]
16. Exploiting Canonical TGFβ Signaling in Cancer Treatment.
Liu Q; Chen G; Moore J; Guix I; Placantonakis D; Barcellos-Hoff MH
Mol Cancer Ther; 2022 Jan; 21(1):16-24. PubMed ID: 34670783
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in the Development of TGF-β Signaling Inhibitors for Anticancer Therapy.
Lee HJ
J Cancer Prev; 2020 Dec; 25(4):213-222. PubMed ID: 33409254
[TBL] [Abstract][Full Text] [Related]
18. Positron Emission Tomography Imaging of Functional Transforming Growth Factor β (TGFβ) Activity and Benefit of TGFβ Inhibition in Irradiated Intracranial Tumors.
Gonzalez-Junca A; Reiners O; Borrero-Garcia LD; Beckford-Vera D; Lazar AA; Chou W; Braunstein S; VanBrocklin H; Franc BL; Barcellos-Hoff MH
Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):527-539. PubMed ID: 33007434
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
